|
GlaxoSmithKline to fully acquire Cellzome for £61 million
|
15 May 2012 |
|
GSK commences tender offer to acquire Human Genome Sciences for US $13.00 per share in cash
|
11 May 2012 |
|
GlaxoSmithKline and Yale University establish drug discovery collaboration
|
03 May 2012 |
|
GSK confirms offer to acquire Human Genome Sciences for US$13.00 per share in cash
|
20 April 2012 |
|
GSK provides update on corporate responsibility commitments in 2011 report
|
19 April 2012 |
|
GlaxoSmithKline provides further update on divestment of non-core OTC brands
|
15 March 2012 |
|
GSK announces submissions for two influenza vaccines
|
05 March 2012 |
|
GSK and Daiichi Sankyo vaccines joint venture to become largest vaccines company in Japan
|
01 March 2012 |
|
EU and US Regulatory Update - Tykerb/Tyverb® (lapatinib)
|
16 February 2012 |
|
GlaxoSmithKline provides update on divestment of non-core over-the-counter (OTC) brands
|
21 December 2011 |